Spectrofluorometric analysis of new-generation antidepressant drugs in pharmaceutical formulations, human urine, and plasma samples

Spectroscopy (New York)

Volumn 27, Issue 2, 2012, Pages 59-71

  Das, Ruchita S ^a   Agrawal, Y K ^a  

^a GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

Author keywords

Analysis; antidepressant drugs; pharmaceutical formulations; plasma; spectrofluorometer; urine

Indexed keywords

ANALYSIS; ANTIDEPRESSANT DRUG; PHARMACEUTICAL FORMULATION; SPECTROFLUOROMETERS; URINE;

BODY FLUIDS; DRUG PRODUCTS; PLASMAS;

DRUG DOSAGE;

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ACCURACY; ARTICLE; BLOOD SAMPLING; DRUG DETERMINATION; DRUG FORMULATION; LIMIT OF QUANTITATION; SPECTROFLUOROMETRY; URINALYSIS;

EID: 84866349204     PISSN: 07124813     EISSN: 1875922X     Source Type: Journal    
DOI: 10.1155/2012/567207     Document Type: Article

References (18)

1. Potter W. Z., Hollister L. E., Katzung B. G., Antidepressant agents. Basic and Clinical Pharmacology 2007 New York, NY, USA McGraw-Hill 475 480
2. Rang H. P., Dale M. M., Ritter J. M., Flower J. M., Rang & Dale's Pharmacology 2007 Elsevier, Churchill Livingstone
3. Eap C. B., Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. Journal of Chromatographic Science 1998 36 7 365 371 2-s2.0-0032112115 (Pubitemid 128659155)
4. Gunnar T., Mykkänen S., Ariniemi K., Lillsunde P., Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. Journal of Chromatography B 2004 806 2 205 219 2-s2.0-2542479783 10.1016/j.jchromb.2004.04.005 (Pubitemid 38686509)
5. Mandrioli R., Saracino M. A., Ferrari S., Berardi D., Kenndler E., Raggi M. A., HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma. Journal of Chromatography B 2006 836 1-2 116 119 2-s2.0-33646254118 10.1016/j.jchromb.2006.03.026
6. Esrafili A., Yamini Y., Shariati S., Hollow fiber-based liquid phase microextraction combined with high-performance liquid chromatography for extraction and determination of some antidepressant drugs in biological fluids. Analytica Chimica Acta 2007 604 2 127 133 2-s2.0-35748967893 10.1016/j.aca.2007.10.012 (Pubitemid 350046252)
7. Patel B. N., Sharma N., Sanyal M., Shrivastav P. S., Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method. Journal of Chromatography B 2009 877 3 221 229 2-s2.0-58149197503 10.1016/j.jchromb.2008.12.008
8. Jain D. S., Sanyal M., Subbaiah G., Pande U. C., Shrivastav P., Rapid and sensitive method for the determination of sertraline in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Journal of Chromatography B 2005 829 1-2 69 74 2-s2.0-28844433327 10.1016/j.jchromb.2005. 09.035 (Pubitemid 41773466)
9. Labat L., Deveaux M., Dallet P., Dubost J. P., Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. Journal of Chromatography B 2002 773 1 17 23 2-s2.0-0037097057 10.1016/S1570-0232(01)00623-7 (Pubitemid 34518266)
10. Pucci V., Fanali S., Sabbioni C., Raggi M. A., Separation of eleven central nervous system drugs by capillary zone electrophoresis. Journal of Separation Science 2002 25 1096 1100
11. Skoog D. A., West D. M., Principles of Instrumental Analysis 1985 Philadelphia, Pa, USA Holt Sounder
12. Walash M. I., Belal F., El-Enany N., El-Mansi H., Spectrophotometric determination of the antidepressants sertraline and paroxetine HCl using 2,4-dinitrofluorobenzene. International Journal of Biomedical Science 2010 6 3 252 259 2-s2.0-77957328874
13. Amin A. S., Dessouki H. A., Moustafa M. M., Ghoname M. S., Spectrophotometric methods for sertraline hydrochloride and/or clidinium bromide determination in bulk and pharmaceutical preparations. Chemical Papers 2009 63 6 716 722 2-s2.0-70350400605 10.2478/s11696-009-0069-8
14. Bebawy L. I., El-Kousy N., Suddik J. K., Shokry M., Spectrophotometric determination of fluoxetine and sertraline using chloranil, 2, 3 dichloro-5, 6 dicyano benzoquinone and iodine. Journal of Pharmaceutical and Biomedical Analysis 1999 21 1 133 142 2-s2.0-0032848133 10.1016/S0731-7085(99)00101-6 (Pubitemid 29430149)
15. Darwish I. A., Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms. Journal of AOAC International 2005 88 1 38 45 2-s2.0-13444257683 (Pubitemid 40207013)
16. ICH [Stability Testing of New Drug Substances and Products (Q1AR2)], International Conference on Harmonization, Food and Drug Administration, USA, November 1996 and February 2003
17. ICH [Validation of Analytical procedures: methodology (Q2AR1)], International Conference on Harmonization, Food and Drug Admination, USA, November 1996 and November 2005
18. Moffat A. C., Osselton M. D., Widdop B., Clarke's Analysis of Drugs and Poisons 2004 London, UK Pharmaceutical Press